Distinct roles for lymphotoxin-α and tumor necrosis factor in the control of Leishmania donovani infection

American Journal of Pathology

Volumn 165, Issue 6, 2004, Pages 2123-2133

  Engwerda, Christian R ^a   Ato, Manabu ^b,c   Stäger, Simona ^b   Alexander, Clare E ^b   Stanley, Amanda C ^a   Kaye, Paul M ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; EXPERIMENTAL MOUSE; GRANULOMA; HEMATOPOIETIC CELL; HEPATITIS; INFECTION SENSITIVITY; LEISHMANIA DONOVANI; LEISHMANIASIS; LEUKOCYTE MIGRATION; LIVER SINUSOID; LYMPHOID ORGAN; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOSENSITIVITY; T LYMPHOCYTE; UPREGULATION;

EID: 9644260723     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63262-2     Document Type: Article

References (61)

1. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501
2. Muller U, Jongeneel CV, Nedospasov SA, Lindahl KF, Steinmetz M: Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature 1987, 325:265-267
3. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF: Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993, 72:847-856
4. Lawton P, Nelson J, Tizard R, Browning JL: Characterization of the mouse lymphotoxin-beta gene. J Immunol 1995, 154:239-246
5. Pokholok DK, Maroulakou IG, Kuprash DV, Alimzhanov MB, Kozlov SV, Novobrantseva TI, Turetskaya RL, Green JE, Nedospasov SA: Cloning and expression analysis of the murine lymphotoxin beta gene. Proc Natl Acad Sci USA 1995, 92:674-678
6. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Korner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001, 15:533-543
7. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA: A lymphotoxin-beta-specific receptor. Science 1994, 264:707-710
8. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL, Tarakhovsky A, Rajewsky K, Nedospasov SA, Pfeffer K: Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 1997, 94:9302-9307
9. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA: Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997, 6:491-500
10. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K: The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998, 9:59-70
11. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF: LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998, 8:21-30
12. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Kontgen F, Fazekas de St Groth B, Sedgwick JD: Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 1997, 27:2600-2609
13. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997, 94:8093-8098
14. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996, 184:1397-1411
15. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML: Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995, 155:1685-1693
16. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science, 264:703-707
17. Kuprash DV, Alimzhanov MB, Tumanov AV, Grivennikov SI, Shakhov AN, Drutskaya LN, Marino MW, Turetskaya RL, Anderson AO, Rajewsky K, Pfeffer K, Nedospasov SA: Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice. Mol Cell Biol 2002, 22:8626-8634
18. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kranke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467
19. Rothe J, Bluethmann H, Gentz R, Lesslauer W, Steinmetz M: Genomic organization and promoter function of the murine tumor necrosis factor receptor beta gene. Mol Immunol 1993, 30:165-175
20. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563
21. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW: Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 2000, 68:6289-6293
22. Wilhelm P, Ritter U, Labbow S, Donhauser N, Rollinghoff M, Bogdan C, Korner H: Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol 2001, 166:4012-4019
23. Sedgwick JD, Riminton DS, Cyster JG, Korner H: Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000, 21:110-113
24. Beutler B, van Huffel C: Unraveling function in the TNF ligand and receptor families. Science 1994, 264:667-668
25. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988, 141:2407-2412
26. Cuff CA, Sacca R, Ruddle NH: Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol 1999, 162:5965-5972
27. Sacca R, Cuff CA, Lesslauer W, Ruddle NH: Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. J Immunol 1998, 160:485-491
28. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ: Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 2001, 193:239-246
29. Schluter D, Kwok LY, Lutjen S, Soltek S, Hoffmann S, Korner H, Deckert M: Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J Immunol 2003, 170:6172-6182
30. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Sickle QD, Kaye PM: Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 2002, 195:1371-1377
31. Magez S, Stijlemans B, Caljon G, Eugster HP, De Baetselier P: Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction. Infect Immun 2002, 70:1342-1351
32. Bryceson ADM: Leishmaniasis. Manson's Tropical Diseases. Edited by GC Cook. London, W. B. Saunders, 1996, pp 1213-1245
33. Wilson ME, Sandor M, Slum AM, Young BM, Metwali A, Elliott D, Lynch RG, Weinstock JV: Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol 1996, 156:2231-2239
34. Smelt SC, Engwerda CR, McCrossen M, Kaye PM: Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol 1997, 158:3813-3821
35. McElrath MJ, Murray HW, Cohn ZA: The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med 1988, 167:1927-1937
36. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, Granelli-Piperno A, Bogdan C: Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 1992, 148:1858-1863
37. Tumang MC, Keogh C, Moldawer LL, Helfgott DC, Teitelbaum R, Hariprashad J, Murray HW: Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol 1994, 153:768-775
38. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, Gorak-Stolinska PM, Kaye PM: A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol 2002, 161:429-437
39. Ato M, Stager S, Engwerda CR, Kaye PM: Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 2002, 3:1185-1191
40. Riminton SD, Korner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD: Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998, 187:1517-1528
41. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM: Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol 1998, 28:669-680
42. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM: Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J Immunol 1998, 161:4153-4160
43. Alexander CE, Kaye PM, Engwerda CR: CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 2001, 31:1199-1210
44. Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, Peterson P, Wang Y, Ware C, Fu YX: Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 2003, 4:1121-1127
45. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH: NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996, 156:4707-4714
46. Fogler WE, Volker K, Watanabe M, Wigginton JM, Roessler P, Brunda MJ, Ortaldo JR, Wiltrout RH: Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas. J Immunol 1998, 161:6014-6021
47. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL: Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol 1992, 149:3881-3888
48. Murray HW, Nathan CF: Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 1999, 189:741-746
49. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992, 10:411-452
50. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314
51. Hochman PS, Majeau GR, Mackay F, Browning JL: Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J Inflamm 1995, 46:220-234
52. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Hori M, Nakamura Y, Tanaka T: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32:650-654
53. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP: In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003, 33:469-475
54. Um JY, An NH, Kim HM: TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 2003, 21:167-171
55. Wang T, Chen W, Chen C, Huang L, Ko Y: Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-alpha-308 and lymphotoxin-alpha-Ncol in Taiwan's children. Clin Exp Allergy 2004, 34:184-188
56. Bouqbis L, Akhayat O, Garchon HJ, Calafell F, Izaabel H: TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens 2003, 61:72-79
57. Fernandes Filho JA, Vedeler CA, Myhr KM, Nyland H, Pandey JP: TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity 2002, 35:377-380
58. Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, Wordsworth BP, Kwiatkowski D: The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum 2003, 48:90-96
59. Garrote JA, Arranz E, Telleria JJ, Castro J, Calvo C, Blanco-Quiros A: TNF alpha and LT alpha gene polymorphisms as additional markers of celiac disease susceptibility in a DQ2-positive population. Immunogenetics 2002, 54:551-555
60. Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, Han H, Serretti A: TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res 2003, 61:39-45
61. Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK: Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 2004, 72:60-65